DecisionPoint Financial’s AbbVie ABBV Stock Holding History

DecisionPoint Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.16K	Buy	16 +3	+23%	+$769	﹤0.01%	301
2026 Q2	$3.26K	Sell	13 -19	-59%	-$4.09K	﹤0.01%	271
2026 Q1	$6.96K	Sell	32 -16	-33%	-$3.55K	﹤0.01%	203
2025 Q4	$11K	Buy	48 +16	+50%	+$3.64K	﹤0.01%	190
2025 Q3	$7.82K	Hold	32	–	–	﹤0.01%	152
2025 Q2	$6.08K	Buy	+32	New	+$5.95K	﹤0.01%	168
2023 Q4	–	Sell	-35	Closed	-$5.22K	–	211
2023 Q3	$5.22K	Hold	35	–	–	﹤0.01%	155
2023 Q2	$4.72K	Hold	35	–	–	﹤0.01%	141
2023 Q1	$5.58K	Hold	35	–	–	﹤0.01%	130
2022 Q4	$5.66K	Buy	+35	New	+$5.37K	﹤0.01%	110

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

DecisionPoint Financial's ABBV Position: Q3 2026 in Review

DecisionPoint Financial increased its AbbVie (ABBV) stake by 23% in Q3 2026, buying an estimated $769 and bringing the position to 16 shares worth $4.16K. The position accounts for ﹤0.01% of the portfolio, ranked #301.

DecisionPoint Financial first reported a position in ABBV in Q4 2022 and has held it in 10 quarters since. The position peaked at $11K in Q4 2025. 1,779 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

DecisionPoint Financial held 16 shares of AbbVie worth $4.16K as of Q3 2026.
DecisionPoint Financial bought 3 AbbVie shares in Q3 2026, an estimated $769.
AbbVie made up ﹤0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #301 holding.
DecisionPoint Financial first reported a position in AbbVie in Q4 2022 and has held it in 10 quarters since.
DecisionPoint Financial's AbbVie position peaked at $11K in Q4 2025.
1,779 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.